POEMs

Aspirin in Low Doses Decreases Preeclampsia Risk

 


FREE PREVIEW. AAFP members and paid subscribers: Log in to get free access. All others: Purchase online access.


FREE PREVIEW. Purchase online access to read the full version of this article.

Am Fam Physician. 2014 Sep 1;90(5):331.

Clinical Question

Is low-dose aspirin effective in decreasing the likelihood of preeclampsia?

Bottom Line

Low-dose aspirin—ranging from 60 to 100 mg per day—beginning as early as the second trimester decreases the risk of preeclampsia, preterm birth, and intrauterine growth retardation in women who are at high risk of preeclampsia. No harms to the mother or newborn were identified in the studies. (Level of Evidence = 1a)

Synopsis

To perform this systematic review, these authors searched four databases, including the Cochrane Central Register of Controlled Trials, to identify 15 English-language randomized controlled trials that evaluated the ability of low-dose aspirin to decrease the risk of preeclampsia, preterm birth, and intrauterine growth restriction. They also evaluated two additional observational studies to assess harms. Two investigators independently selected articles for inclusion, and two investigators evaluated study quality, which was generally high. The studies enrolled almost 12,000 patients, with two studies contributing 76% of the total. Low-dose aspirin reduced preeclampsia by 2 to 5 percentage points, depending on baseline risk. Intrauterine growth retardation was also reduced by 1 to 5 percentage points, as was preterm birth (2 to 4 percentage points). No harms were identified. There was no significant heterogeneity for these outcomes.

Study design: Systematic review

Funding source: Government

Setting: Outpatient (any)

Reference: Henderson JT, Whitlock EP, O'Connor E, Senger CA, Thompson JH, Rowland MG. Low-dose aspirin for prevention of morbidity and mortality from preeclampsia: a systematic evidence review for the U.S. Preventive Services Task Force. Ann Intern Med.. 2014; 160( 10): 695– 703.

POEMs (patient-oriented evidence that matters) are provided by EssentialEvidence Plus, a point-of-care clinical decision support system published by Wiley-Blackwell. For more information, please see http://www.essentialevidenceplus.com. Copyright Wiley-Blackwell. Used with permission.

For definitions of levels of evidence used in POEMs, see http://www.essentialevidenceplus.com/product/ebm_loe.cfm?show=oxford.

To subscribe to a free podcast of these and other POEMs that appear in AFP,search in iTunes for “POEM of the Week” or go to http://goo.gl/3niWXb.

A collection of POEMs published in AFP is available at http://www.aafp.org/afp/poems.



 

Want to use this article elsewhere? Get Permissions


More in AFP


Editor's Collections


Related Content


More in Pubmed

MOST RECENT ISSUE


Sep 15, 2016

Access the latest issue of American Family Physician

Read the Issue


Email Alerts

Don't miss a single issue. Sign up for the free AFP email table of contents.

Sign Up Now

Navigate this Article